| 000 | 01082 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514002734.0 | ||
| 264 | 0 | _c20010712 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0009-9104 | ||
| 024 | 7 |
_a10.1046/j.1365-2249.2001.01565.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatel, S Y | |
| 245 | 0 | 0 |
_aFrom black magic to science: understanding the rationale for the use of intravenous immunoglobulin to treat inflammatory myopathies. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cMay 2001 |
||
| 300 |
_a169-71 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMyositis _xetiology |
| 650 | 0 | 4 |
_aNervous System Autoimmune Disease, Experimental _xetiology |
| 700 | 1 | _aKumararatne, D S | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 124 _gno. 2 _gp. 169-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2249.2001.01565.x _zAvailable from publisher's website |
| 999 |
_c11351838 _d11351838 |
||